MS vs TMO: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Morgan Stanley · Financial Services
$223.17
-1802.9% upside to fair value
Grade D
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
MS trades at a lower forward P/E
(20.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
TMO |
| Current Price |
$223.17 |
$464.61 |
| Fair Value Estimate |
$-3,800.42 |
$498.27 |
| Upside to Fair Value |
-1802.9%
|
+7.2%
|
| Market Cap |
$352.0B |
$172.7B |
| Forward P/E |
20.1x
|
25.2x
|
| EV / EBITDA |
21.9x
|
19.1x
|
| Price / Sales |
2.9x
|
3.8x
|
| Price / FCF |
-334.6x
|
25.6x
|
| Revenue Growth YoY |
+18.8%
|
+6.2%
|
| Gross Margin |
58.0%
|
39.4%
|
| Operating Margin |
19.5%
|
17.8%
|
| Return on Equity |
16.4%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
3.91%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Morgan Stanley is a leading global financial services firm with a strong focus on wealth management and institutional securities, generating $70.6 billion in net revenues in 2025. The company benefits from a durable competitive moat driven by its fee-based wealth franchise, strong profitability with a 15.1% net margin, and steady capital returns. However, the stock is significantly overvalued, tr…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
MS |
TMO |
| Zone Low |
$-2,850.32 |
$373.70 |
| Zone High |
$-3,230.36 |
$423.53 |
| In Buy Zone? |
No
|
No
|